
Opinion|Videos|April 2, 2024
Evolving Treatment Landscape in Prostate Cancer
Author(s)Matthew Smith, MD, PhD, Brian Helfand, MD, PhD
Experts on prostate cancer discuss how treatment has evolved over the years, focusing on doublet and triplet therapy and their utility.
Advertisement
Video Player is loading.
Episodes in this series

Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Christof Vulsteke, MD, PhD, breaks down findings, implications of KEYNOTE-905
2
The UroOnc Minute: Active Surveillance for Intermediate-risk Prostate Cancer, with Michael Leapman, MD, MHS
3
Petros Grivas, MD, on the significance of a perioperative regimen for cisplatin-ineligible MIBC
4
The Significance of KEYNOTE-905 in Muscle-Invasive Bladder Cancer
5





















